Ou et al. reported that elevated expression of Polo-like kinase 2 (Plk2) in CRC samples stabilizes Cyclin E by suppressing FBXW7 expression, thereby promoting CRC growth (Ou et al., 2016). Here, PLK2 is linked to colorectal carcinoma.